Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:24 PM
Ignite Modification Date:
2025-12-24 @ 4:24 PM
NCT ID:
NCT04626466
Eligibility Criteria:
For inclusion in the study, patients must be affiliated to the national or local social security, and must meet all the following criteria :
Inclusion Criteria:
* Patients must be ≥ 18 years old and \< 80 years old
* Performance Status 0 to 2
* Histologically-confirmed diagnosis of : prostate cancer ; cervical cancer ; vaginal cancer ; endometrial cancer ; middle or low rectal cancer ; anal duct carcinoma
* At inclusion, patients must have : Haemoglobin \> 10 g/dL ; Leucocytes 4.0-11.0 g/L ; Neutrophils 1.5-7.7 g/L ; Platelets 150-400 g/L
* Signed informed consent from the patient
Exclusion Criteria:
* History of haematologic disorders, leucopathia or imune system diseases
* At inclusion, patients must not have : Haemoglobin \< 10 g/dL or \> 18 g/dL (men) \> 16 g/dL (women) ; Leucocytes \< 4.0 or \> 11.0 g/L ; Neutrophils \< 1.5 or \> 7.7 g/L ; Platelets \< 150 or \> 400 g/L
* Patients previously treated with radiation therapy or with chemotherapy
* Patients with metastatic cancer
* Patients presenting tumor classified histologically as sarcomatoid
* Patients placed under judicial protection, guardianship, or supervision
* Women that are pregnant or breast-feeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
79 Years
Study:
NCT04626466
Study Brief:
Protocol Section:
NCT04626466